The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts

The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts

By Neuroendocrine Cancer FoundationEducation
Download on the App Store

The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts episodes

  • Episode 26: What to Know About Lung NETs

    What are lung NETs? What is DIPNECH? How is lung NET similar or different from lung cancer? Dr. Vineeth Sukrithan from Ohio State University Comprehensive Cancer Center gives a comprehensive overview of lung NET and DIPNECH, including the work-up and treatment options. He also discusses open clinical trials and exciting advances in lung NET research on the horizon.

    For more information, visit LACNETS.org/podcast/24. 

    For more information, visit LACNETS.org.

    For more information, visit NCF.net. 

    45 min
  • Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)

    What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.

    For more information, visit LACNETS.org/podcast/24. 

    For more information, visit NCF.net. 

    46 min
  • Episode 24: What to Know About Grade 3 Well-differentiated NETs

    What are grade 3 NETs and how is it different from grade 3 NEC and other types of NETs? Dr. Mohamad (Bassam) Sonbol from Mayo Clinic in Phoenix, Arizona, enlightens us on this fairly new entity, including treatment options, treatment sequencing and clinical trials.

    For more information, visit LACNETS.org/podcast/24. 

    For more information, visit NCF.net. 

    41 min
  • Episode 23: What to Know About Hindgut & Appendiceal NETs

    What are Hindgut NETs (distal colon and rectum), and how are they treated? How is rectal NET different from rectal cancer? What makes appendiceal NETs difficult to diagnose? Dr. Hagen Kennecke from Providence Cancer Institute in Portland, Oregon, shares insights on the diagnosis and management of Hindgut NETs and appendix NET.

    For more information, visit LACNETS.org/podcast23 for the transcript and resources. 

    For more information, visit NCF.net. 

    32 min
  • What to Know about Pancreatic NETs

    What is the difference between Pancreatic Neuroendocrine Tumor (PNET) and Pancreatic Cancer? Where exactly is the pancreas located and why is the tumor location important? NET Oncologist Dr. Jennifer Chan from Dana-Farber Cancer Institute takes us through how some treatments, imaging and blood work are unique to PNETs. She also expounds on several ongoing and active trials.

    For more information, visit NCF.net. 

    45 min
  • Episode 21: What to Know About Small Bowel NETs

    How are small bowel NETs diagnosed, treated, and monitored? How is it different from other types of NETs? What are some exciting new treatments for small bowel NETs? NET oncologist, Dr. David Zhen of Fred Hutch Cancer Center in Seattle answers 10 common questions about small bowel NETs.

    Visit LACNETS.org/podcast21 for the transcript and resources. 

    For more information, visit NCF.net. 

    46 min
  • Episode 20: "Gastric NET, Gastrinomas & Zollinger-Ellison Syndrome (ZES)"

     Gastroenterologist and Neuroendocrinologist Dr. David C. Metz discusses important concepts in Gastric NET, Gastrinomas and Zollinger-Ellison Syndrome, including detection, treatments, associated risks and monitoring. He also lends valuable insight on ulcers, MEN and proton pump inhibitors.

    Visit LACNETS.org/podcast20 for the transcript and resources. 

    For more information, visit NCF.net. 

    1 hr 2 min
  • Episode 19: "Beyond the Basics: The Pathology of NET"

    Take a glimpse through the microscope and learn how pathology determines your NET diagnosis and guides treatment. How does one interpret differing Ki-67 results from the same specimen? Why might a patient have two different Ki-67 results from different specimens? How does pathology distinguish G3 well-differentiated NET from NEC? How does pathology help with NET tumors of unknown origin? NET pathologist Dr. Andrew M. Bellizzi from the University of Iowa sheds light on just how much information a tiny tissue sample may contain.

    For more information, visit NCF.net. 

    1 hr 1 min
  • Episode 18: "Mental Health & NETs" with Dr. Karen Kersting

    What are the common mental health issues associated with NET? How can they be managed? How does NET impact young adults, NET patients and children of NET patients?  Health psychologist Dr. Kersting of the Medical College of Wisconsin, elaborates on mental health challenges facing NET patients and their loved ones. Hear coping strategies for anxiety, eating and sleeping difficulties, fatigue and depression. Dr. Kersting discusses what you can expect when meeting a mental health professional and why supporting your mental health is an integral part of your overall care.

    Visit
    LACNETS.Org/Podcast18

    For more information, visit NCF.net. 

    49 min
  • Episode 17: Key Considerations for NET Surgery

     How do surgeons decide the type, extent, and approach of NET surgery? NET surgeon Dr. Alexandra Gangi of Cedars-Sinai answers 10 common questions about what to expect before, during, and after NET surgery. Gain insight on preparing for surgery and what is important for your surgeon to know about your recovery goals. Dr. Gangi’s comprehensive approach illustrates why surgeons are an integral part of your NET medical team. 

    For more information, visit NCF.net. 

    42 min

About The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts

From the publisher's feed

The Neuroendocrine Cancer Foundation Podcast is a monthly series where we interview neuroendocrine cancer experts on various NET topics. Each expert will answer the top 10 FAQs in their area of…